1-7 of 7
Robert H. Getzenberg
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase Ib/II Study of Sabizabulin, a Novel Oral Cytoskeleton Disruptor, in Men with Metastatic Castration-resistant Prostate Cancer with Progression on an Androgen Receptor–targeting Agent

Mark C. Markowski, Ronald Tutrone, Christopher Pieczonka, K. Gary Barnette, Robert H. Getzenberg, Domingo Rodriguez, Mitchell S. Steiner, Daniel R. Saltzstein, Mario A. Eisenberger, Emmanuel S. Antonarakis
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (13): 2789–2795.
https://doi.org/10.1158/1078-0432.CCR-22-0162
Published: 01 July 2022
View article titled, A Phase Ib/II Study of Sabizabulin, a Novel Oral Cytoskeleton Disruptor, in Men with Metastatic Castration-resistant Prostate Cancer with Progression on an Androgen Receptor–targeting Agent
Open the PDF for A Phase Ib/II Study of Sabizabulin, a Novel Oral Cytoskeleton Disruptor, in Men with Metastatic Castration-resistant Prostate Cancer with Progression on an Androgen Receptor–targeting Agent in another window
Includes: Supplementary data
Journal Articles

Orally Bioavailable Androgen Receptor Degrader, Potential Next-Generation Therapeutic for Enzalutamide-Resistant Prostate Cancer

Suriyan Ponnusamy, Yali He, Dong-Jin Hwang, Thirumagal Thiyagarajan, Rene Houtman, Vera Bocharova, Bobby G. Sumpter, Elias Fernandez, Daniel Johnson, Ziyun Du, Lawrence M. Pfeffer, Robert H. Getzenberg, Iain J. McEwan, Duane D. Miller, Ramesh Narayanan
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (22): 6764–6780.
https://doi.org/10.1158/1078-0432.CCR-19-1458
Published: 15 November 2019
View article titled, Orally Bioavailable Androgen Receptor Degrader, Potential Next-Generation Therapeutic for Enzalutamide-Resistant Prostate Cancer
Open the PDF for Orally Bioavailable Androgen Receptor Degrader, Potential Next-Generation Therapeutic for Enzalutamide-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Decreased Expression of Cyr61 Is Associated with Prostate Cancer Recurrence after Surgical Treatment

Katherine B. D'Antonio, Lucianna Schultz, Roula Albadine, Alison M. Mondul, Elizabeth A. Platz, George J. Netto, Robert H. Getzenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (23): 5908–5913.
https://doi.org/10.1158/1078-0432.CCR-10-1200
Published: 06 December 2010
View article titled, Decreased Expression of Cyr61 Is Associated with Prostate Cancer Recurrence after Surgical Treatment
Open the PDF for Decreased Expression of Cyr61 Is Associated with Prostate Cancer Recurrence after Surgical Treatment in another window
Journal Articles

Evaluation of Colon Cancer–Specific Antigen 2 as a Potential Serum Marker for Colorectal Cancer

Eddy S. Leman, Robert E. Schoen, Ahmed Magheli, Lori J. Sokoll, Daniel W. Chan, Robert H. Getzenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (5): 1349–1354.
https://doi.org/10.1158/1078-0432.CCR-07-4110
Published: 03 March 2008
View article titled, Evaluation of Colon Cancer–Specific Antigen 2 as a Potential Serum Marker for Colorectal Cancer
Open the PDF for Evaluation of Colon Cancer–Specific Antigen 2 as a Potential Serum Marker for Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Functional Characterization of the Bladder Cancer Marker, BLCA-4

Thu-Suong Van Le, Julie Myers, Badrinath R. Konety, Timothy Barder, Robert H. Getzenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (4): 1384–1391.
https://doi.org/10.1158/1078-0432.CCR-0455-03
Published: 20 February 2004
View article titled, Functional Characterization of the Bladder Cancer Marker, BLCA-4
Open the PDF for Functional Characterization of the Bladder Cancer Marker, BLCA-4 in another window
Journal Articles

Nuclear Matrix Protein Alterations Associated with Colon Cancer Metastasis to the Liver

Gisela Brünagel, Robert E. Schoen, Anthony J. Bauer, Barbara N. Vietmeier, Robert H. Getzenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (10): 3039–3045.
Published: 01 October 2002
View article titled, Nuclear Matrix Protein Alterations Associated with Colon Cancer Metastasis to the Liver
Open the PDF for Nuclear Matrix Protein Alterations Associated with Colon Cancer Metastasis to the Liver in another window
Journal Articles

Detection of Bladder Cancer Using a Novel Nuclear Matrix Protein, BLCA-4

Badrinath R. Konety, Thu-Suong T. Nguyen, Rajiv Dhir, Roger S. Day, Michael J. Becich, Walter M. Stadler, Robert H. Getzenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (7): 2618–2625.
Published: 01 July 2000
View article titled, Detection of Bladder Cancer Using a Novel Nuclear Matrix Protein, BLCA-4
Open the PDF for Detection of Bladder Cancer Using a Novel Nuclear Matrix Protein, BLCA-4 in another window